You are here

Pfizer

Second time's the charm? Pfizer tries again with OTC Viagra in the U.K.

Fierce Pharma

Tue, 03/28/17 - 11:49 pm

erectile dysfunction

Pfizer Up on Bristol-Myers Takeover Talk

Investopedia

Mon, 03/27/17 - 11:43 pm

Bristol-Myers Squibb

Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All?

Barron's

Mon, 03/27/17 - 11:41 pm

Bristol-Myers Squibb

3 Tremendously Promising Diabetes Drugs Potentially on the Way

Motley Fool

Sun, 03/26/17 - 12:02 pm

Lexicon Pharmaceuticals

Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor

BioPharma Dive

Sun, 03/26/17 - 12:00 pm

Pfizer CEO Read: Healthcare overhaul needs to 'get the incentives right'

Fierce Pharma

Fri, 03/24/17 - 09:40 am

healthcare reform

FDA approves Pfizer, German Merck immunotherapy for skin cancer

Yahoo/Reuters

Fri, 03/24/17 - 09:38 am

metastatic Merkel cell carcinoma

Pfizer’s Lyrica Ineffective for Sciatica Pain

Investopedia

Thu, 03/23/17 - 09:25 am

7 Pharma Plays With Emerging Market Potential

Barron's

Wed, 03/22/17 - 10:59 pm

emerging markets

Bristol-Myers Squibb

Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin

BioPharma Dive

Tue, 03/21/17 - 09:55 am

Bristol-Myers Squibb

SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in vaccines

Endpoints

Tue, 03/21/17 - 09:46 am

pneumococcal disease

Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome

Investopedia

Mon, 03/20/17 - 10:54 am

clinical trials

non-small cell lung cancer

Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

Yahoo

Thu, 03/16/17 - 09:45 am

rheumatoid arthritis

Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?

Motley Fool

Wed, 03/15/17 - 09:52 pm

Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco

Forbes

Wed, 03/15/17 - 10:20 am

drug development

Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria

Yahoo

Tue, 03/14/17 - 09:59 am

gram-negative bacteria

Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer

Endpoints

Tue, 03/14/17 - 09:38 am

Merck and Pfizer prep for battle with SGLT2, combo diabetes filings

Fierce Pharma

Mon, 03/13/17 - 10:18 am

SGLT2 inhibitor

Boehringer Ingelheim

Pfizer runs away with pharma brand ad-spending crown, Nielsen data shows

Fierce Pharma

Mon, 03/13/17 - 10:06 am

Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis

Endpoints

Thu, 03/9/17 - 11:34 am

acute lymphocytic leukemia

Pages